Beta Bionics is a biotechnology company that provides software to reduce the burden of diabetes care.
Beta Bionics has raised $60.0M in total funding. The most recent round was Series E. The last funding was announced in November 2024.
Beta Bionics's investors include Eli Lilly, Sands Capital Ventures, Wellington Management, Novo Nordisk, Perceptive Advisors.
Beta Bionics is headquartered in Irvine, United States.
Beta Bionics is a biotechnology company that provides software to reduce the burden of diabetes care.
Beta Bionics is at the Series E stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Beta Bionics — Funding & Investors." VCBacked, November 13, 2024, https://www.vcbacked.co/company/beta-bionics. Accessed July 29, 2026.
VCBacked. (2024). Beta Bionics — Funding & Investors. Retrieved July 29, 2026, from https://www.vcbacked.co/company/beta-bionics
{{cite web |title=Beta Bionics — Funding & Investors |url=https://www.vcbacked.co/company/beta-bionics |website=VCBacked |access-date=July 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated